Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 12, 2004, Pages 1317-1323

  Kettle, Anthony J ^a   Chan, Timothy ^b   Osberg, Iris ^b   Senthilmohan, Revathy ^b   Chapman, Anna L P ^b   Mocatta, Tessa J ^b   Wagener, Jeffery S ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NONE

Author keywords

Hypochlorous acid; Neutrophil; Oxidative stress; Protein carbonyl

Indexed keywords

3 CHLOROTYROSINE; BIOLOGICAL MARKER; HYPOCHLOROUS ACID; MYELOPEROXIDASE; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

AIRWAY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; HUMAN CELL; INFANT; INFLAMMATION; LUNG LAVAGE; MALE; NEUTROPHIL; OXIDATION; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

BRONCHOALVEOLAR LAVAGE FLUID; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; MALE; OXIDATIVE STRESS; PEROXIDASE; PROTEINS;

EID: 10644263047     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200311-1516OC     Document Type: Article

References (66)

1. Ratjen F, Doring G. Cystic fibrosis. Lancet 2003;361:681-689.
2. De Rose V. Mechanisms and markers of airway inflammation in cystic fibrosis. Eur Respir J 2002;19:333-340.
3. Brown RK, Kelly FJ. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res 1994;36:487-493.
4. Brown RK, Wyatt H, Price JF, Kelly FJ. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 1996;9:334-339.
5. Kettle AJ, Winterbourn CC. Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Rep 1997;3:3-15.
6. Klebanoff SJ. Oxygen Metabolites from Phagocytes. In: Gallin JI, Snyderman R, editors. Inflammation: basic principles and clinical correlates. Philadelphia: Lippincott Williams & Wilkins; 1999, pp. 721-768.
7. Regelmann WE, Schneider LA, Fahrenkrug SC, Gray BH, Johnson S, Herron JM, Clawson CC, Clawson DJ, Wangensteen OD. Proteinase-free myeloperoxidase increases airway epithelial permeability in a whole trachea model. Pediatr Pulmonol 1997;24:29-34.
8. Slungaard A, Mahoney JR. Thiocyanate is the major substrate for eosinophil peroxidase in physiologic fluids. J Biol Chem 1991;266:4903-4910.
9. Meyer KC, Zimmerman J. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. J Lab Clin Med 1993;121:654-661.
10. Mohammed JR, Mohammed BS, Pawluk LJ, Bucci DM, Baker NR, Davis WB. Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum. J Lab Clin Med 1988;112:711-720.
11. Regelmann WE, Siefferman CM, Herron JM, Elliot GR, Clawson CC, Gray BH. Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis. Pediatr Pulmonol 1995;19:1-9.
12. Brown RK, Kelly FJ. Role of free radicals in the pathogenesis of cystic fibrosis. Thorax 1994;49:738-742.
13. van der Vliet A, Eiserich JP, Marelich GP, Halliwell B, Cross CE. Oxidative stress in cystic fibrosis: does it occur and does it matter? Adv Pharmacol 1997;38:491-513.
14. Dominguez C, Gartner S, Linan S, Cobos N, Moreno A. Enhanced oxidative damage in cystic fibrosis patients. Biofactors 1998;8:149-153.
15. van der Vliet A, Nguyen MN, Shigenaga MK, Eiserich JP, Marelich GP, Cross CE. Myeloperoxidase and protein oxidation in cystic fibrosis. Am J Physiol 2000;279:L537-L546.
16. Portal BC, Richard M, Faure HS, Hadjian A, Favier AE. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995;61:843-847.
17. Kahn TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151:1075-1082.
18. Hammond KB, Abman SH, Sokol RJ, Accurso FJ. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N Engl J Med 1991;325:769-774.
19. Hoiby N. Hemophilus influenzae, Staphylococcus aureus, Pseudomonas cepacia, and Pseudomonas aeruginosa in patients with cystic fibrosis. Chest 1988;94:97S-103S.
20. Thomas EL, Grisham MB, Jefferson MM. Cytotoxicity of chloramines. Methods Enzymol 1986;132:585-593.
21. Bozeman PM, Learn DB, Thomas EL. Assay of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. J Immunol Methods 1990;126:125-133.
22. Kettle AJ, Winterbourn CC. Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid. Biochem J 1988;252:529-536.
23. Wu W, Samoszuk MK, Comhair SAA, Thomassen MJ, Farver CF, Dweik RA, Kavuru MS, Erzurum SC, Hazen SL. Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest 2000;105: 1455-1463.
24. Chapman ALP, Senthilmohan R, Winterbourn CC, Kettle AJ. Comparison of mono and dichlorinated tyrosines with carbonyls for detection of hypochlorous acid-modified proteins. Arch Biochem Biophys 2000; 377:95-100.
25. Buss IH, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 1997;23:361-366.
26. Aldridge RE, Chan TP, Van Dalen CJ, Senthilmohan R, Town GI, Winn MC, Venge P, Kettle AJ. Eosinophil peroxidase produces hypobromous acid in the airways of stable asthmatics. Free Radic Biol Med 2002;33:847-856.
27. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986; 60:532-538.
28. Domigan NM, Charlton TS, Duncan MW, Winterbourn CC, Kettle AJ. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J Biol Chem 1995;270:16542-16548.
29. Fu S, Wang H, Davies M, Dean R. Reactions of hypochlorous acid with tyrosine and peptidyl-tyrosyl residues give dichlorinated and aldehydic products in addition to 3-chlorotyrosine. J Biol Chem 2000;275:10851-10858.
30. Winterbourn CC, Chan TP, Buss IH, Inder TE, Mogridge N, Darlow BA. Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infant plasma: associations with chronic lung disease and retinopathy and effect of selenium supplementation. Pediatr Res 2000;48:84-90.
31. Buss IH, Darlow BA, Winterbourn CC. Elevated protein carbonyls, lipid peroxidation products and myeloperoxidase in tracheal aspirates from premature infants. Pediatr Res 2000;47:640-645.
32. Cantin A. Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med 1995;151:939-941.
33. Hoiby N. Inflammation and infection in cystic fibrosis-hen or egg? Eur Respir J 2001;17:4-5.
34. Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 2001;32:356-366.
35. Berger M. Lung inflammation early in cystic fibrosis: bugs are indicted, but the defense is guilty. Am J Respir Crit Care Med 2002;165:857-858.
36. Griese M, Ramakers J, Krasselt A, Starosta V, Van Koningsbruggen S, Fischer R, Ratjen F, Mullinger B, Huber RM, Maier K, et al. Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J Respir Crit Care Med 2004;169:822-828.
37. Wijkstrom-Frei C, El-Chemaly S, Ali-Rachedi R, Gerson C, Cobas MA, Forteza R, Salathe M, Conner GE. Lactoperoxidase and human airway host defense. Am J Respir Cell Mol Biol 2003;29:206-212.
38. Van Dalen CJ, Whitehouse MW, Winterbourn CC, Kettle AJ. Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J 1997;327:487-492.
39. Linsdell P. Relationship between anion binding and anion permeability revealed by mutagenesis within the cystic fibrosis transmembrane conductance regulator chloride channel pore. J Physiol 2001;531:51-66.
40. Miller ME, Cosgriff JM, Schwartz RH. Sweat bromide excretion in cystic fibrosis. J Lab Clin Med 1986;108:406-410.
41. Buss IH, Senthilmohan R, Darlow BA, Mogridge N, Kettle AJ, Winterbourn CC. 3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: association with adverse respiratory outcome. Pediatr Res 2003;53:455-462.
42. Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 1997;99:2075-2081.
43. Upston JM, Niu X, Brown AJ, Mashima R, Wang H, Senthilmohan R, Kettle AJ, Dean RT, Stocker R. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am J Pathol 2002;160:701-710.
44. Worlitzsch D, Herberth G, Ulrich M, Döring G. Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur Respir J 1998;11:377-383.
45. Pattison DI, Davies MJ. Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds. Chem Res Toxicol 2001;14:1453-1464.
46. Chapman AL, Winterbourn CC, Brennan SO, Jordan TW, Kettle AJ. Characterisation of non-covalent oligomers of proteins treated with hypochlorous acid. Biochem J 2003;375:33-40.
47. 1-proteinase inhibitor and human neutrophil myeloperoxidase. Biochemistry 1985;24:1941-1945.
48. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-active forms. Science 1992;258:1898-1902.
49. Ischiropoulos H, al-Mehdi AB. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett 1995;364:279-282.
50. Jobsis Q, Raatgeep HC, Schellekens SL, Kroesbergen A, Hop WC, de Jongste JC. Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur Respir J 2000;16:95-100.
51. Ho LP, Innes JA, Greening AP. Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. Eur Respir J 1998;12:1290-1294.
52. Meng QH, Springall DR, Bishop AE, Morgan K, Evans TJ, Habib S, Gruenert DC, Gyi KM, Hodson ME, Yacoub MH, et al. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol 1998; 184:323-331.
53. Linnane SJ, Keatings VM, Costello CM, Moynihan JB, O'Conner CM, Fitzgerald MX, McLoughlin P. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med 1998;158:207-212.
54. Jones KL, Hegab AH, Hillman BC, Simpson KL, Jinkins PA, Grisham MB, Owens MW, Sato E, Robbins RA. Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr Pulmonol 2000;30:79-85.
55. Ho LP, Innes JA, Greening AP. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 1998;53:680-684.
56. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393-397.
57. Henderson WR. Eosinophil Peroxidase: Occurence and biological function. In: Everse J, Grisham MB, editors. Peroxidases, Chemistry and Biology. Boston: CRC Press; 1990, p. 105-121.
58. El-Chemaly S, Salathe M, Baier S, Conner GE, Forteza R. Hydrogen peroxide-scavenging properties of normal human airway secretions. Am J Respir Crit Care Med 2003;167:425-430.
59. Koller DY, Urbanek R, Gotz M. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am J Respir Crit Care Med 1995;152:629-633.
60. Koller DY, Gotz M, Eichler I, Urbanek R. Eosinophilic activation in cystic fibrosis. Thorax 1994;49:496-499.
61. 2. Arch Biochem Biophys 1987;258:381-390.
62. Winklhofer-Roob BM. Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance. Acta Paediatr 1994;Suppl. 395:49-57.
63. Linsdell P, Hanrahan JW. Glutathione permeability of CFTR. Am J Physiol 1998;275:C323-C326.
64. Gao L, Kim KJ, Yankaskas JR, Forman HJ. Abnormal glutathione transport in cystic fibrosis airway epithelia. Am J Physiol 1999;277:L113-L118.
65. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 2000;16:534-554.
66. Dakin CJ, Numa AH, Wang H, Morton JR, Vertzyas CC, Henry RL. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 2002;165:904-910.